CD8A and neoplasm: To validate the association between PODO447 immunoreactivity and low level of immune infiltration obtained in Cohort D, we optimized a multiplex opal immunofluorescent panel that includes pan-CK, to distinguish between tumor and stromal areas and CD8 and CD20 immune markers and used this panel to stain the samples from the Cohort A (Figure 5A).